DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,060,756 | +7.0% | 8,306 | +3.5% | 0.09% | 0.0% |
| Q2 2023 | $1,926,499 | -19.7% | 8,027 | -15.6% | 0.09% | -43.1% |
| Q1 2023 | $2,398,161 | +22.2% | 9,515 | +28.7% | 0.16% | +15.1% |
| Q4 2022 | $1,962,610 | -62.8% | 7,394 | -63.8% | 0.14% | -67.4% |
| Q3 2022 | $5,279,000 | +315.3% | 20,437 | +307.7% | 0.43% | +265.0% |
| Q2 2022 | $1,271,000 | -42.2% | 5,013 | -33.1% | 0.12% | -34.3% |
| Q1 2022 | $2,198,000 | -81.3% | 7,493 | -79.1% | 0.18% | -85.7% |
| Q4 2021 | $11,772,000 | +14.4% | 35,779 | +5.8% | 1.24% | +4.9% |
| Q3 2021 | $10,293,000 | +23.6% | 33,811 | +9.0% | 1.18% | +19.5% |
| Q2 2021 | $8,328,000 | +3127.9% | 31,032 | +2610.2% | 0.99% | +2814.7% |
| Q1 2021 | $258,000 | -10.4% | 1,145 | -11.6% | 0.03% | -8.1% |
| Q4 2020 | $288,000 | -89.9% | 1,295 | -90.2% | 0.04% | -91.8% |
| Q3 2020 | $2,853,000 | – | 13,249 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |